Switch From Dual Regimens Based on Dolutegravir Plus a Reverse Transcriptase Inhibitor to E/C/F/TAF in Virologically Suppressed, HIV-1 Infected Patients (Be-OnE)
Condition(s):HIV-1-infectionLast Updated:February 9, 2024Terminated
Hide Studies Not Open or Pending
Condition(s):HIV-1-infectionLast Updated:February 9, 2024Terminated
Condition(s):HIV InfectionsLast Updated:February 23, 2017Completed
Condition(s):HIV InfectionsLast Updated:July 18, 2019Completed
Condition(s):HIV InfectionsLast Updated:April 10, 2008Completed
Condition(s):HIVLast Updated:September 2, 2016Completed
Condition(s):Saquinavir/Ritonavir BID or Lopinavir/Ritonavir BIDLast Updated:March 30, 2015Withdrawn
Condition(s):HIV InfectionsLast Updated:March 13, 2024Completed
Condition(s):Pregnancy; HIV-1-infectionLast Updated:April 6, 2022Withdrawn
Condition(s):HIV/AIDSLast Updated:April 12, 2023Completed
Condition(s):HIVLast Updated:January 19, 2018Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.